slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
32,32 EGP | +2,41% | -0,15% | -9,09% |
Vakgebied
Verkoop per activiteit
EGP in miljoen | 2017 | Gewicht | 2018 | Gewicht | Delta |
---|---|---|---|---|---|
Medical
85,1
%
| 1 271 | 88,5 % | 1 381 | 85,1 % | +8,68% |
Consumer Care
14,9
%
| 165 | 11,5 % | 242 | 14,9 % | +46,62% |
Verkoop per regio
EGP in miljoen | 2017 | Gewicht | 2018 | Gewicht | Delta |
---|---|---|---|---|---|
Egypt
100,0
%
| 1 436 | 100,0 % | 1 623 | 100,0 % | +13,04% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | - | - | |
Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | - | |
Chairman | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Henry Antaki
BRD | Director/Board Member | - | - |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Najib Shabei
BRD | Director/Board Member | - | - |
Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 83 514 200 | 2 434 272 ( 2,915 %) | 0 | 2,915 % |
Bedrijfsgegevens
GlaxoSmithKline (Egypt)
Boomerang Building 1st Section City Centre, No. 46
11835, Cairo
+
http://www.gsk.com/en-gb/contact-us/worldwide/egypt/Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
-9,09% | 56,35 mln. | |
+24,17% | 556 mld. | |
-6,33% | 354 mld. | |
+19,90% | 331 mld. | |
+7,95% | 296 mld. | |
+13,45% | 233 mld. | |
+6,04% | 201 mld. | |
-10,51% | 193 mld. | |
-12,26% | 143 mld. | |
-6,47% | 144 mld. |
- Beurs
- Aandelen
- Koers BIOC
- Onderneming GlaxoSmithKline S.A.E